Results 161 to 170 of about 94,283,903 (258)

In Silico to In Cerebro—Development of the Orexin Receptor Antagonist “Photorexant” for Photomodulation In Vitro and in Mouse Brains

open access: yesAngewandte Chemie International Edition, Volume 65, Issue 42, 12 October 2026.
Following a structure‐based design approach, photoswitchable derivatives of the FDA‐approved drug suvorexant were designed, docked, synthesized, and characterized pharmacologically at the orexin 1 and 2 receptors (OX1R and OX2R). Optimized “photorexant” showed up to an 11‐fold difference in IC50 between photoisomers, enabled dynamic and reversible ...
Marcus Angermann   +10 more
wiley   +1 more source

Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review. [PDF]

open access: yesPLoS One
Arzayus-Patiño L   +4 more
europepmc   +1 more source

Threatened Miscarriage: Evidence-Based Status and Advances in Western Medical Treatments. [PDF]

open access: yesInt J Womens Health
Wang Y   +8 more
europepmc   +1 more source

Severe Burn Injury Alters Expression of Adrenergic Receptor Transcripts in a Rodent Model. [PDF]

open access: yesEur Burn J
Knappskog K   +13 more
europepmc   +1 more source

Oxidized phosphatidylcholines inhibit airway smooth muscle β2-adrenergic receptors via protein kinase C. [PDF]

open access: yesAm J Respir Cell Mol Biol
Vaghasiya J   +12 more
europepmc   +1 more source

Nicotinic Acetylcholine Receptor Signaling Activates Beige Adipocytes and Mediates Systemic Metabolism. [PDF]

open access: yesDiabetes
Liu S   +14 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy